CIK 0001875091 · Non-accelerated filer<br>Emerging growth company
NeuroSense Therapeutics Ltd.
Sign in to watch- Ticker
- NRSN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 972-9-9531142
- Business address
- 11 HAMENOFIM ST., BUILDING B, HERZLIYA, Israel, 4672562
Securities
- NRSN Ordinary Shares Nasdaq
- NRSNW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Ben-Noon Alon Chief Executive Officer | Purchase | +250,000 | $0.80 | $200K | 4,534,233 |
| 2026-06-16 | Eisenberg Or Chief Financial Officer | Purchase | +250,000 | $0.80 | $200K | 1,504,050 |
| 2026-03-26 | Eisenberg Or Chief Financial Officer | Grant or award | +200,000 | 1,254,050 | ||
| 2026-03-26 | Russek-Blum Niva Chief Technology Officer | Grant or award | +200,000 | 467,953 | ||
| 2026-03-26 | Binder Hagit General Manager | Grant or award | +200,000 | 521,806 |
Page 1 of 1 · 5 trades